Close

More on ETNB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (3/20/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

89bio Inc. (NQ:ETNB)
Delayed: 9.94 -0.02 (0.2%)
Prev. Close $9.96  
Open$10.05 
52 Wk High$ 
52 Wk Low$ 
Day High$10.26 
Day Low$9.67 
P/E N/A  
EPS$ 
Volume1,217,457 

Friends, Peers and Foes (?): AKRO (more...)

Dec 6, 2023 05:30 PM After-hours movers: Cerevel surges on takeover, Chewy falls following results
Dec 6, 2023 04:40 PM Form 424B5 89bio, Inc.
Dec 6, 2023 04:36 PM 89bio Inc. (ETNB) Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Dec 6, 2023 04:36 PM 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Dec 6, 2023 04:03 PM Form 8-K 89bio, Inc. For: Dec 04
Dec 4, 2023 07:06 AM 89bio (ETNB) Reaches Alignment with the FDA and EMA on Phase 3 Program for Pegozafermin in Nonalcoholic Steatohepatitis
Dec 4, 2023 07:02 AM Form 8-K 89bio, Inc. For: Dec 04
Dec 4, 2023 07:00 AM 89bio Reaches Alignment with the FDA and EMA on Phase 3 Program for Pegozafermin in Nonalcoholic Steatohepatitis (NASH); Program Initiation Planned in the First Half of 2024
Nov 27, 2023 08:02 AM 89bio (ETNB) Announces New Positive Long-Term Data from the ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Nonalcoholic Steatohepatitis
Nov 27, 2023 08:02 AM Form 8-K 89bio, Inc. For: Nov 27
View All Articles

Entities mentioned with ETNB

View All Entities